U-251 MG Luciferase Reporter Cell Line
1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
The U-251 MG Luciferase cell line is transformed from U-251 MG cell, expressing the firefly luciferase gene. The cell constitutively express Luciferase.
Product Code | U-251 MG Luciferase Cell Line |
Species | Human |
Cat.No | ABC-RC354H |
Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Product Category | Transfected Stable Cell Lines |
Size/Quantity | 1 vial |
Cell Type | Neuron |
Shipping Info | Dry Ice |
Growth Conditions | 37 ℃, 5% CO2 |
Source Organ | Brain |
Disease | Human CNS Cancer |
Biosafety Level | 1 |
Storage | Liquid Nitrogen |
Product Type | Reporter Stable Cell Line |
Host Cell | U-251 MG Cell Line |
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
For research use only
The U-251 MG Luciferase Reporter Cell Line is a genetically modified glioblastoma cell line that expresses the luciferase enzyme. This modification allows researchers to study cellular processes and gene expression by detecting luminescent signals produced by the luciferase reaction.
This cell line is used in brain cancer research, particularly for studying glioblastoma. It helps in investigating tumor biology, signal transduction pathways, and the efficacy of therapeutic agents. The luciferase reporter system facilitates real-time, non-invasive monitoring of gene expression and cellular responses, enabling high-throughput screening and functional assays.
The luciferase reporter system enhances glioblastoma research by providing a sensitive and quantifiable method to measure cellular processes and gene expression. The luminescent signal correlates with biological activity, allowing researchers to monitor the effects of treatments and environmental changes in real-time, thereby improving the understanding of glioblastoma biology and aiding in the development of potential therapies.